These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 26253567
1. Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. Brown MJ, Williams B, MacDonald TM, Caulfield M, Cruickshank JK, McInnes G, Sever P, Webb DJ, Salsbury J, Morant S, Ford I. BMJ Open; 2015 Aug 07; 5(8):e008086. PubMed ID: 26253567 [Abstract] [Full Text] [Related]
4. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial. Xue C, Zhou C, Yang B, Lv J, Dai B, Yu S, Wang Y, Zhao G, Mei C. BMJ Open; 2017 Feb 24; 7(2):e013672. PubMed ID: 28237959 [Abstract] [Full Text] [Related]
8. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D. J Clin Hypertens (Greenwich); 2008 Jun 24; 10(6):450-8. PubMed ID: 18550935 [Abstract] [Full Text] [Related]
9. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension. Heran BS, Chen JM, Wang JJ, Wright JM. Cochrane Database Syst Rev; 2010 Jan 20; (1):CD008167. PubMed ID: 20091662 [Abstract] [Full Text] [Related]
12. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M. Clin Exp Hypertens; 2008 Oct 20; 30(7):553-64. PubMed ID: 18855259 [Abstract] [Full Text] [Related]
13. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L. Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):137-42. PubMed ID: 22329591 [Abstract] [Full Text] [Related]
15. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y, Neutel JM, Schumacher H. Clin Ther; 2005 Nov 01; 27(11):1795-805. PubMed ID: 16368450 [Abstract] [Full Text] [Related]
16. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension. White WB, Davidai G, Schumacher H. J Hum Hypertens; 2009 Dec 01; 23(12):817-25. PubMed ID: 19357698 [Abstract] [Full Text] [Related]
17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul 01; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related]